These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23960446)

  • 1. Higher Prevalence of Klebsiella pneumoniae Extended-Spectrum β-Lactamase in Patients on Renal Replacement Therapy.
    Lee HL; Whang DH; Park DW; Lee YJ; Kim YH; Chin HJ; Kim S; Koo HS
    J Korean Med Sci; 2013 Aug; 28(8):1187-93. PubMed ID: 23960446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.
    Boix-Palop L; Xercavins M; Badía C; Obradors M; Riera M; Freixas N; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
    Int J Antimicrob Agents; 2017 Aug; 50(2):197-202. PubMed ID: 28552471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Xiamen, China.
    Deng J; Li YT; Shen X; Yu YW; Lin HL; Zhao QF; Yang TC; Li SL; Niu JJ
    J Glob Antimicrob Resist; 2017 Dec; 11():23-27. PubMed ID: 28842361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
    Mosqueda-Gómez JL; Montaño-Loza A; Rolón AL; Cervantes C; Bobadilla-del-Valle JM; Silva-Sánchez J; Garza-Ramos U; Villasís-Keever A; Galindo-Fraga A; Palacios GM; Ponce-de-León A; Sifuentes-Osornio J
    Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections caused by extended-spectrum β-lactamase-producing Enterobacterales after rectal colonization with ESBL-producing Escherichia coli or Klebsiella pneumoniae.
    Denkel LA; Maechler F; Schwab F; Kola A; Weber A; Gastmeier P; Pfäfflin F; Weber S; Werner G; Pfeifer Y; Pietsch M; Leistner R
    Clin Microbiol Infect; 2020 Aug; 26(8):1046-1051. PubMed ID: 31809805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysis.
    Yang CC; Li SH; Chuang FR; Chen CH; Lee CH; Chen JB; Wu CH; Lee CT
    BMC Infect Dis; 2012 Sep; 12():206. PubMed ID: 22947300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and computed tomography features of extended-spectrum β-lactamase-producing Klebsiella pneumoniae liver abscess.
    Ren Y; Wang H; Chang Z; Liu Z
    BMC Infect Dis; 2020 Jun; 20(1):416. PubMed ID: 32539687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy.
    Yang CC; Wu CH; Lee CT; Liu HT; Chen JB; Chiu CH; Chen CH; Chuang FR
    Int J Infect Dis; 2014 Nov; 28():3-7. PubMed ID: 25200093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: First systematic review and meta-analysis from Iran.
    Beigverdi R; Jabalameli L; Jabalameli F; Emaneini M
    J Glob Antimicrob Resist; 2019 Sep; 18():12-21. PubMed ID: 30685458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of control group selection in the analysis of risk factors for extended spectrum beta-lactamase-producing Klebsiella pneumoniae infections. A prospective controlled study.
    Behar PR; Teixeira PJ; Fachel JM; Kalil AC
    J Hosp Infect; 2008 Feb; 68(2):123-9. PubMed ID: 18192077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases.
    Peña C; Pujol M; Ardanuy C; Ricart A; Pallares R; Liñares J; Ariza J; Gudiol F
    Antimicrob Agents Chemother; 1998 Jan; 42(1):53-8. PubMed ID: 9449260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What may be lurking in the hospital undergrowth? Inapparent cross-transmission of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
    Skally M; Duffy F; Burns K; Doyle D; Foley S; Thomas T; Collins C; Smyth E; Turton J; Humphreys H
    J Hosp Infect; 2014 Nov; 88(3):156-61. PubMed ID: 25280879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications and risk factors of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection in children: a case-control retrospective study in a medical center in southern Taiwan.
    Kuo KC; Shen YH; Hwang KP
    J Microbiol Immunol Infect; 2007 Jun; 40(3):248-54. PubMed ID: 17639166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
    Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
    Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low prevalence of rmpA and high tendency of rmpA mutation correspond to low virulence of extended spectrum β-lactamase-producing Klebsiella pneumoniae isolates.
    Yu WL; Lee MF; Tang HJ; Chang MC; Chuang YC
    Virulence; 2015; 6(2):162-72. PubMed ID: 25830726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an outbreak due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a pediatric intensive care unit transplant population.
    Rebuck JA; Olsen KM; Fey PD; Langnas AN; Rupp ME
    Clin Infect Dis; 2000 Dec; 31(6):1368-72. PubMed ID: 11096004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for infection by extended-spectrum beta-lactamase producing Klebsiella pneumoniae in a tertiary hospital in Salvador, Brazil.
    Silva N; Oliveira M; Bandeira AC; Brites C
    Braz J Infect Dis; 2006 Jun; 10(3):191-3. PubMed ID: 17568851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase.
    Peña C; Pujol M; Ardanuy C; Ricart A; Pallarés R; Liñares J; Ariza J; Gudiol F
    J Hosp Infect; 2001 Jan; 47(1):53-9. PubMed ID: 11161899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics, risk factors and outcomes of Klebsiella pneumoniae pneumonia developing secondary Klebsiella pneumoniae bloodstream infection.
    Chen J; Li J; Huang F; Fang J; Cao Y; Zhang K; Zhou H; Cai J; Cui W; Chen C; Zhang G
    BMC Pulm Med; 2023 Mar; 23(1):102. PubMed ID: 36978069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Klebsiella pneumoniae pneumonia in patients with rheumatic autoimmune diseases: clinical characteristics, antimicrobial resistance and factors associated with extended-spectrum β-lactamase production.
    Liu Y; Liu Y; Dai J; Liu A; Li Y; Xu J; Yu X; Liu J; Zhu H
    BMC Infect Dis; 2021 Apr; 21(1):366. PubMed ID: 33865323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.